CAGNETTI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.584
EU - Europa 923
AS - Asia 265
AF - Africa 82
Totale 2.854
Nazione #
US - Stati Uniti d'America 1.578
IT - Italia 369
UA - Ucraina 144
IE - Irlanda 97
SG - Singapore 90
SE - Svezia 86
CN - Cina 74
DE - Germania 63
CI - Costa d'Avorio 61
FR - Francia 49
DK - Danimarca 45
TR - Turchia 41
HK - Hong Kong 29
GB - Regno Unito 26
KR - Corea 22
MA - Marocco 21
FI - Finlandia 20
RO - Romania 10
NL - Olanda 9
CA - Canada 5
IN - India 5
JP - Giappone 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
EE - Estonia 1
LV - Lettonia 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 2.854
Città #
Chandler 186
Fairfield 171
Jacksonville 151
Ashburn 135
Dublin 95
Seattle 85
Boardman 72
Houston 70
Wilmington 70
Woodbridge 68
Abidjan 61
Singapore 53
Redmond 51
New York 48
Cambridge 45
Des Moines 39
Lawrence 37
Princeton 37
San Mateo 33
Hong Kong 29
Turin 28
Ann Arbor 27
San Diego 25
Centro 21
Milan 19
Porto 16
Rome 15
Beijing 9
London 9
Naples 9
Timisoara 9
Cagliari 8
Genoa 8
Washington 8
Noisy-le-sec 7
Ancona 6
Civitanova Marche 6
Florence 6
Los Angeles 6
Bonn 5
Guangzhou 5
Helsinki 5
Padova 5
Pune 5
San Casciano In Val Di Pesa 5
Tolentino 5
Dallas 4
Kilburn 4
Macerata 4
Ripa Teatina 4
Squinzano 4
Villar Perosa 4
Fermo 3
Hounslow 3
Islington 3
Jinhua 3
Little Rock 3
Matelica 3
Norwalk 3
Ottawa 3
Rivoli 3
Santa Ana 3
Shanghai 3
Auburn Hills 2
Bari 2
Bologna 2
Cantu 2
Carugate 2
Castelletto Stura 2
Desio 2
Dong Ket 2
East Peoria 2
Ferentino 2
Frankfurt am Main 2
Grugliasco 2
Hefei 2
Isola del Liri 2
Jiaxing 2
Marche 2
Mediglia 2
Monza 2
Nanjing 2
Napoli 2
Palermo 2
Pavia 2
Pesaro 2
Piossasco 2
Pisa 2
Prescot 2
Redwood City 2
Salerno 2
Savigliano 2
Termeno 2
Toronto 2
Venice 2
Acerenza 1
Acton 1
Argelato 1
Barchi 1
Cantù 1
Totale 1.939
Nome #
Distrofia miotonica tipo 1 (Malattia di Steinert) e disturbi del sonno: prevalenza e severità dei disturbi respiratori durante il sonno al momento della diagnosi e scarsa consapevolezza da parte del paziente 238
Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke 127
Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage 108
Brivaracetam add-on for refractory focal epilepsy 107
Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage 104
Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis 96
Neurocognitive functioning and cerebrovascular reactivity after carotid endarterectomy 95
Progressive Multifocal Myelopathy or Multiple Sclerosis? 89
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis 88
The P-wave terminal force in embolic strokes of undetermined source 87
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis 87
Imitation strategies of callosotomized patients. 83
Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage 80
Skin features in myotonic dystrophy type 1: An observational study 78
Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy 75
Predictors of cognitive functioning after carotid revascularization 75
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis 73
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 73
Lacosamide monotherapy for partial onset seizures 72
Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis 72
Palliative non-resective surgery for drug-resistant epilepsy 70
Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review 70
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: An evidence-based review of efficacy, safety and place in therapy 69
Endovascular treatment of symptomatic vertebral artery stenosis: A systematic review and meta-analysis 69
Atopic myelitis is not restricted to Japanese patients 68
Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage 68
How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis 65
Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy 65
Neurogenic muscle hypertrophy. 64
Lacosamide during pregnancy and breastfeeding 61
Psychiatric comorbidities in patients from seven families with autosomal dominant cortical tremor, myoclonus, and epilepsy 59
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 54
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis 53
Mystery case responses 52
The latency of post-stroke epilepsy can predict drug resistance 49
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice 43
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 39
Individualized Prediction of Drug Resistance in People with Post-Stroke Epilepsy: A Retrospective Study 27
Totale 2.952
Categoria #
all - tutte 16.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020127 0 0 0 0 0 0 36 2 37 0 5 47
2020/2021732 53 48 76 17 75 86 59 42 65 110 66 35
2021/2022335 33 61 21 5 8 23 11 18 13 39 28 75
2022/2023609 52 72 58 35 30 78 3 36 142 4 81 18
2023/2024446 62 17 36 60 68 88 11 27 15 13 12 37
2024/2025324 104 78 26 9 30 49 28 0 0 0 0 0
Totale 2.952